Which opioids should be avoided in a patient with impaired renal function who is being started on naltrexone?

Opioids to Avoid Before Starting Naltrexone in Renal Impairment

In patients with renal impairment (GFR <30 mL/min/1.73 m²) who are being started on naltrexone, avoid morphine, codeine, meperidine, tramadol, and tapentadol due to accumulation of neurotoxic metabolites; use hydrocodone, oxycodone, and hydromorphone only with extreme caution and dose reduction. 1, 2, 1

Critical Opioids to Avoid in Renal Impairment

Absolutely Contraindicated

• Morphine: Accumulation of morphine-3-glucuronide and morphine-6-glucuronide causes opioid-induced neurotoxicity, including myoclonus, hyperalgesia, and seizures 1, 2
• Codeine: Renally cleared metabolites accumulate, causing neurologic toxicity 1, 3
• Meperidine: Active metabolites accumulate with high risk of neurotoxicity and seizures 1
• Tramadol: Not recommended in GFR <30 mL/min/1.73 m² or ESRD 1, 2, 1
• Tapentadol: Not recommended in GFR <30 mL/min/1.73 m² or ESRD 1

Use With Extreme Caution (Require Dose Adjustment)

• Hydrocodone: Requires careful dose adjustment and frequent monitoring for neurologic adverse effects 1, 3
• Oxycodone: Primarily eliminated in urine; requires careful titration and frequent monitoring for accumulation 1, 2
• Hydromorphone: Metabolites may cause opioid neurotoxicity; use with caution and adjust dosage 1, 3

Safer Alternatives in Renal Impairment

Preferred opioids with no active metabolites:

• Fentanyl: Preferred for renal insufficiency or ESRD (no active metabolites) 1, 2, 1
• Sufentanil: Safe in renal impairment 1
• Methadone: Fecally excreted, can be rotated to in renal impairment, but requires experienced clinician due to long half-life (15-120 hours) and risk of accumulation 1, 2
• Buprenorphine: Considered first-line in CKD management 4, 5

Critical Naltrexone-Specific Considerations

Opioid-Free Period Requirements

Patients must be completely opioid-free for a minimum of 7-10 days before starting naltrexone to avoid precipitated withdrawal 6

• Short-acting opioids (heroin, morphine IR): >12 hours since last use 7
• Extended-release formulations (OxyContin): >24 hours since last use 7
• Methadone: Patients may be vulnerable to precipitated withdrawal for up to 2 weeks 6
• Buprenorphine: May require up to 2 weeks opioid-free period 6

Naloxone Challenge Test

Before initiating naltrexone, perform a naloxone challenge test if there is any question of occult opioid dependence 6:

• IV route: Inject 0.2 mg naloxone, observe for 30 seconds for withdrawal signs 6
• Do not perform if patient shows clinical signs of withdrawal or has opioids in urine 6

Clinical Pitfalls to Avoid

Renal Function Monitoring

Perform more frequent clinical observation and opioid dose adjustment in patients with renal or hepatic impairment 2

Risk of Precipitated Withdrawal

Naltrexone's high binding affinity can precipitate severe withdrawal if opioids are still present 6:

• Withdrawal precipitated by naltrexone may be severe enough to require hospitalization 6
• This is different from spontaneous withdrawal and can be life-threatening 6

Overcoming Naltrexone Blockade

Warn patients that attempting to overcome naltrexone blockade with large opioid doses can lead to serious injury, coma, or death 6:

• Naltrexone produces complete blockade of opioid euphoric effects 6
• If emergency opioid analgesia is needed, greater-than-usual doses may be required, resulting in deeper and more prolonged respiratory depression 6

Post-Naltrexone Sensitivity

Patients who previously used opioids may be more sensitive to lower opioid doses after naltrexone discontinuation, increasing overdose risk 6